Oxidative Stress in Spinocerebellar Ataxia Type 7 Is Associated with Disease Severity

被引:0
作者
Y. Torres-Ramos
A. Montoya-Estrada
B. Cisneros
K. Tercero-Pérez
G. León-Reyes
N. Leyva-García
Oscar Hernández-Hernández
Jonathan J. Magaña
机构
[1] National Perinatology Institute (INPer),Department of Immunobiochemistry
[2] Center of Research and Advanced Studies (CINVESTAV-IPN),Department of Genetics and Molecular Biology
[3] Rehabilitation and Social Inclusion Center of Veracruz (CRIS-DIF),Laboratory of Genomic Medicine, Department of Genetics
[4] National Rehabilitation Institute-Luis Guillermo Ibarra Ibarra (INR-LGII),undefined
来源
The Cerebellum | 2018年 / 17卷
关键词
Spinocerebellar ataxia type 7; Oxidative stress; Blood biomarkers; Lipid oxidation; Protein oxidation; Antioxidant defense;
D O I
暂无
中图分类号
学科分类号
摘要
Spinocerebellar ataxia type 7 is a neurodegenerative inherited disease caused by a CAG expansion in the coding region of the ATXN7 gene, which results in the synthesis of polyglutamine-containing ataxin-7. Expression of mutant ataxin-7 disturbs different cell processes, including transcriptional regulation, protein conformation and clearance, autophagy, and glutamate transport; however, mechanisms underlying neurodegeneration in SCA7 are still unknown. Implication of oxidative stress in the pathogenesis of various neurodegenerative diseases, including polyglutamine disorders, has recently emerged. We perform a cross-sectional study to determine for the first time pheripheral levels of different oxidative stress markers in 29 SCA7 patients and 28 age- and sex-matched healthy subjects. Patients with SCA7 exhibit oxidative damage to lipids (high levels of lipid hydroperoxides and malondialdehyde) and proteins (elevated levels of advanced oxidation protein products and protein carbonyls). Furthermore, SCA7 patients showed enhanced activity of various anti-oxidant enzymes (glutathione reductase, glutathione peroxidase, and paraoxonase) as well as increased total anti-oxidant capacity, which suggest that activation of the antioxidant defense system might occur to counteract oxidant damage. Strikingly, we found positive correlation between some altered oxidative stress markers and disease severity, as determined by different clinical scales, with early-onset patients showing a more severe disturbance of the redox system than adult-onset patients. In summay, our results suggest that oxidative stress might contribute to SCA7 pathogenesis. Furthermore, oxidative stress biomarkers that were found relevant to SCA7 in this study could be useful to follow disease progression and monitor therapeutic intervention.
引用
收藏
页码:601 / 609
页数:8
相关论文
共 277 条
[1]  
David G(1997)Cloning of the SCA7 gene reveals a highly unstable CAG repeat expansion Nat Genet 17 65-70
[2]  
Abbas N(1998)Molecular and clinical correlations in autosomal dominant cerebellar ataxia with progressive macular dystrophy (SCA7) Hum Mol Genet 7 165-170
[3]  
Stevanin G(1994)Autosomal dominant cerebellar ataxia with pigmentary macular dystrophy. A clinical and genetic study of eight families Brain 117 445-460
[4]  
Durr A(2008)Molecular pathogenesis and cellular pathology of spinocerebellar ataxia type 7 neurodegeneration Cerebellum 7 138-149
[5]  
Yvert G(2015)A comprehensive clinical and genetic study of a large Mexican population with spinocerebellar ataxia type 7 Neurogenetics 16 11-21
[6]  
Cancel G(2015)Spinocerebellar ataxia type 7: a neurodegenerative disorder with peripheral neuropathy Eur Neurol 73 173-178
[7]  
David G(1996)The gene for autosomal dominant cerebellar ataxia type II is located in a 5-cM region in 3p12-p13: genetic and physical mapping of the SCA7 locus Am J Hum Genet 59 1328-1336
[8]  
Durr A(2001)Striking anticipation in spinocerebellar ataxia type 7: the infantile phenotype J Neurol 248 911-914
[9]  
Stevanin G(2005)Polyglutamine-expanded spinocerebellar ataxia-7 protein disrupts normal SAGA and SLIK histone acetyltransferase activity Proc Natl Acad Sci U S A 102 8478-8482
[10]  
Cancel G(2005)Polyglutamine-expanded ataxin-7 inhibits STAGA histone acetyltransferase activity to produce retinal degeneration Proc Natl Acad Sci U S A 102 8472-8477